Clinical trials
Observational Dermatomyositis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 8 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 4 |
| National Institute of Environmental Health Sciences (NIEHS) | 4 |
| Duke University | 2 |
| Global Healthy Living Foundation | 1 |
| Kyverna Therapeutics | 1 |
| Mayo Clinic | 1 |
| Myositis International Health & Research Collaborative Alliance Foundation | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| Phoenix Neurological Associates, LTD | 1 |
| University of Central Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatomyositis | 20 |
| Polymyositis | 13 |
| Myositis | 11 |
| Arthritis, Rheumatoid | 5 |
| Autoimmune Diseases | 5 |
| Scleroderma, Systemic | 5 |
| Myositis, Inclusion Body | 4 |
| Scleroderma, Diffuse | 4 |
| Spondylitis, Ankylosing | 4 |
| Arthritis, Psoriatic | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.